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Introduction
The presently available mutagen test sys-
tems are no longer receiving critical ac-
claim by sole virtue of their positive response
to ethyl methanesulfonate (EMS). Rather,
they are being asked to yield answers to such
questions as: how mutagenic is EMS in this
system and, given this number, what does it
imply relative to the genetic risk of EMS
to man? Both of these questions address
themselves to the relevance of the test re-
sults, the first in a quantitative manner, the
second qualitatively, in that it involves eval-
uating species' and systems' differences.
Because this extrapolation of data must
be to a rather complex organism-man-we
are immediately'"face&'with- a- genetic quan-
dary. Or'ganisms -which display thei-r'genetic
repertoires in the simplest, most rapid
manner-and which, therefore, are easiest
to use and most definitive in the answers they
yield-are phylogenetic foreigners to many.
Used alone, one risks banning penicillin on
the basis of toxic effects on gram-positive
bacteria, or, to cite an example more or-
iented to mutagenicity testing, one might
be tempted to place 5-bromodeoxyuridine
(BUdR) on the GRAS list as a result of
testing in thymidine kinase-deficient yeast.
Yet, if we choose to eliminate most of this
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xenomorphism we are faced with expensive,
time-consuming mega-chimp experiments
which relinquish genetic secrets at such a
slow rate that extrapolation to man is done
in a near vacuum of supporting studies,
thus weakening the advantage of evolution-
ary proximity.
One compromise to these extremes has
been to microbialize the mammal. Growing
mammalian somatic cells in tissue culture
accomplishes four aims: (1) over 108 gene-
tically expressive genomes are compacted into
a volume less than that occupied by one
average-size whole mammal; (2) the gen-
eration time and hence the duration of the
experiment-is reduced from months or
years to hours; '(3) definitive genetic stud-
ies, including mutagenicity studies akin to
those heretofore reserved by the microbial
geneticist, can now be performed on mam-
malian cells; and (4) we have preserved
most of the structural and functional pe-
culiarities of the mammalian genome.
However, such cells do not undergo meio-
sis, nor do they posses the differentiated
intricacies which confer upon the whole mam-
mal some degree of protection from a wide
variety of toxic agents (but which can also
activate innocuous compounds into hazardous
ones). For these reasons, such in vitro
systems do not constitute a panacea for
mutagen testing. Like other systems, their
limitations must be defined as ardently as
their advantages are expoited.
December 1973 119The TK+'- Heterozygote System sa 2). [Hycanthone- is a highly efficacious anti-
schistosomal- drug which *had earlier been e a e of m shown to induce .frameshift mutations in cells grown in tissue culture are admirably mo
byL178 mose ympomacel's.'''Salm-onella- (6) -and to intercalate into DNA illustrated by L5178Y mouse lymphoa cells(7>].
This line of transformed cells was frst is-
olated in the late 1950's by Fischer (1). Subsequent studies onra 'different hetero-
They grow well in suspension culture with zygote (TK+/- -3.7.2) with a higher TK+'-
a generation time of 10-11 hr; they dfone i -TK; spontaneous mutation rate (2 x
with 80-100%o efficiency in a soft agar me-+ 10 mutations / locus / generation) show
dium (2,3). We have found (3,4) these cells the wide range of induced mutant frequen-
to be diploid at the thymidine kinase (TK) cies to which this system can respond.-Figure
locus and have developed selection 'media 1 illustrates the relative mutagenicities of
for isolating TK-competent or TK-deficient the three alkylating agents, EMS, MMS
mutants occurring at low frequencies among (methyl methanesulfonate), and EDB (ethy-
cells of the opposite phenotype. Reconstruc- lene dibromide) as a function of their molar
tion experiments show recovery of 80-100%o
of plated mutants under the conditions used.
Table 1 summarizes the genetic and pheno-
typic characteristics of the two homozygotes I0
(TK+/+ and TK-/-) and of the heterozygote 2
(TK+/-) clonal lines that were initially in- .
vestigated (5). Spontaneous mutation rates, 90
TK activities, and mode of isolation are all l0 &MMS M/
compatible with the assigned genotypes. 80i
The TK+/- -+TK-'- (our basic mutagen as- 8
say system) mutation rate was greatly stim- S 70'
ulated by x-irradiation, EMS, and 6
hycanthone-methanesulfonate (3,4,5) (Table ,60
~~~ />~~~EDB
Table 1. Summary of phenotopic and presumed J250 01 genotypic properties at the thymidine kinase
(TK) locus in L5178Y mouse lymphoma 2 7 , EMS
cells." X 40 /
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ C 0
Thymidine kinase
activity,
pmole thymidine
phosphorylated/10'
Spontaneous mutation rate, cells per min
mutations/locus/generation incubation
TK+'+ (BUdR') 61 ± 3.6
1 5 x 10
TK-'- (BUdR') 0
6 x 10-9 /t 1.2 x 10-'
TK+'- (BUdR') 27 ± 1.3
'In all instances, BUdR-sensitive (BUdRa) cells
were THMG (thymidine + hypoxanthine + metho-
trexate + glycine)-resistant (THMGr), and BUdR'
cells were THMG'.
b One mutant only.
e Nine independent revertants.
Conc.(Mx103)
FIGURE 1. Dose: mutagenicity curves for three alky-
lating agents in the TK+'- -- TK-'- muta-
tional assay system. Induced mutant frequencies
(numbier of- BUdR-resistant (TK-'-)- mutant col--
onies per 104 viable cells) following a 2 hr exposure
to the indicated mutagen concentrations (milli-
molar) are compared <main figure); the low dose:
response range is-amplified in-theinset. Up to 1%
mutant frequencie- are inducible by EMS.- -
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cies are obtained by subtracting the mutant
frequency observed in the control culture
from that of each of the treated cultures
and in all instances is expressed in terms
of number of TK-/- mutants per surviving
cell. The vertical and horizontal scales are
exaggerated in the inset to display more
prominently the dose response curves of
MMIS and EDB. Though much less muta-
genic than EMS they still represent a mut-
agenic equivalent of over 600 R of x-ir-
radiation at the higher concentrations (cf.
Table 2.
This system is capable of still better sen-
sitivity, as is shown in Figure 2. Here the
mutagenicity of hycanthone as a function
of concentration is compared with the alky-
lating agents on still further exaggerated
axes. The highest hycanthone concentration
used is slightly more mutagenic than 600 R
of x-irradiation.
So far we have accomplished little except
demonstrate that the TK+'- -+TK-'- system
yields quantitative results and that different
external concentrations of different muta-
gens effect different dose: response curves.
This latter result can give seemingly contra-
dictory results. Thus, by comparing the
curves for hycanthone and EMS (Figs. 2 and
3) one can claim (a) hycanthone is about 40
times as mutagenic as EMS at 104M concen-
tration, and (b) EMS is 25 times as muta-
genic as hycanthone at the highest concentra-
tions examined. Which, if either, of these two
statements is to be used when extrapolating
these data to man's genetic risk, or are they
.~s
c:WMMS
', hconthone
AlEMS
-EDB
0 200 400 600 800 1000
Conc.(MxI06)
FIGURE 2. Further amplification of Figure 1, com-
paring dose-mutagenic response curve of hycan-
thone methanesulfonate with those of the alkylat-
ing agents. 600 R of x-irradiation induces ap-
proximately 3 x 10-4 mutations/locus, less than
the two highest responses to hycanthone.
both relevant? What do such comparisons
mean with respect to the relative efficiencies
with which alkylation or intercalation events
in the DNA can induce mutations?
Partial relief from such questions is ob-
tained by replacing extracellular molar con-
centration of the mutagen as the independent
variable in these figures by some parameter
related to intracellular dose. In this manner
the contribution to mutagenic response of
Table 2. Induced forward mutation rates at the thymidine kinase (TK) locus.
(TK+' -+ TK-'-)
Mutagenic Relative Mutation Rate,
agent Dose survival, % mutations/locus/generation
None (Spontaneous) 100 1.2 x 10-7
X-Irradiation 600 R (136 R/min) 12 3 x 10-4
EMS 10'2 M, 2hr 1.0 2 x 10-'
EMS 10-2'M, 2 hr 10 3 x 10-4
EMS 10-'°M, 2 hr 50 9 x 10-'
Hycanthone 1 X 10-4M, 2 hr 2 5.4 x 10-'
Hycanthone 0.5 x 10-4M, 2 hr 20 3.4 X 10-'
Hyeanthone 0.2 x 10-4M, 2 hr 55 1.0 X 10-'
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FIGURE 3. Mutant frequencies (per 104 viable cells)
induced by three alkylating agents, expressed as a
function of growth inhibition. The curves of
Figures 1 and 2 are made to overlap in their
abscissal range by relating mutagenic response to
a biological (growth inhibition), rather than to a
chemical (molarity) measure.
differences in membrane permeability to and/
or transport of various mutagens would
be minimized. Ideally, this should be number
of mutagen molecules physically associated
with the TK gene, but except for EMS (see
below) such dosimetric relationships have
not yet been established. Instead, we have
chosen growth inhibition as a more easily
assessible index of intracellular-and pos-
sible genomal-concentration.
Growth inhibition is measured in two
steps. First, the rate of growth in suspension
culture is determined for each treated cul-
ture for the combined treatment (2 hr)
and expression (48-72 hr) times (sham-
treated control = 100). Then cloning ef-
ficiencies (relative to Coulter counts) are
assessed for each culture (control = 1.00).
The product of these two figures for each
culture represents the overall growth of that
culture relative to the control (= 100%o);
growth inhibition is obtained by subtracting
these relative growth figures from 100.
The previous data can now be plotted over
a common abscissal range (0-100%o growth
inhibition) as in Figures 3 and 4. Note (Fig.
4) that EMS appears to be a much more
potent mutagen over the whole range of
growth inhibitions covered, while MMS,
hycanthone, and possibly even EDB fall
fairly closely together.
These data are now in a format which
is both quantitative and easily compared with
EMS f |
0
10
5- A5
/r /
A '77X1;hycanthone -"MS
o 20 40 60 80 100
Growth inhibition(%)
FIGURE 4. Same as Figure 3, but with exaggerated
vertical axis and inclusion of hycanthone data.
Note the relative high induction of mutations per
lethal event (slope of curve) for EMS, and the
essential similarity of this index for MMS, EDB
and hycanthone, despite qualitatively different
mutagenic mechanisms (alkylation and base pair
substitutions vs. intercalation and frame-shifts)
involved.
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the mutagenicity-toxicity relationships for
a given compound are not too highly species-
dependent-or, if they are, and if well-
established biochemical or physical difference
in the more xenomorphic systems can ad-
equately explain such differences-then the
data can be directly extrapolated to man and
an estimate of the genetic risk can be
hazarded. The emphasis is, of course, on
high correlations among various test sys-
tems after allowing for their respective pit-
falls.
As a beginning in putting our mutagenicity
test systems to positive social advantage we
have been studying the mutagenicity of a
number of hycanthone analogs possessing
varying degrees of antischistosomal activity.
The mutagenicity-or lack thereof-of one
of these, IA-3 (the 6-chloroindazole deriva-
tive of lucanthone), is compared with that
of hycanthone in Figure 5 as a function of
both molar concentration and growth in-
hibition. At up to 80%o inhibition of growth
this compound is no more than 10%oas muta-
genic as hycanthone. Of course, further test-
ing in other systems is essential before draw-
anth-ne*MS
IA-3
- ycanthone
-MS
- i IA-3
)d 20 40 60 80 100 *0 20 40 60 80
Conc.(MxlO6) Growth inhibition(%)
100
FIGURE 5. Mutagenicity of the 6-chloro-4-methylinda-
zole derivative (IA-3) of hycanthone, relative to
that of hycanthone. Considered as a function of
either concentration or growth inhibition this
compound is nearly nonmutagenic in this system.
ing firm conclusions relative to clinical po-
tential. Especially, the question of whether
hydroxylation of the 4-methyl group occurs
in whole mammals (as it does for lucan-
thone) must be considered, since the hydro-
xymethyl derivative of IA-3 is 3 times as
mutagenic as IA-3 itself (i.e., it is 30%o as
mutagenic as hycanthone).
As alluded to above, these cells readily
lend themselves to dosimetry studies at the
genomal level. Specificially, Patterson (8)
has determined the extent of ethylation of
the DNA over a tenfold range in EMS con-
centration; by comparing these data with
the EMS mutagenicity data an estimated 8
x 10-5 mutations per alkylation occur which
is constant over a 5-fold concentration
range (see Fig. 6). Allowance must still
be made for the unknown fraction of all
possible mutations at the TK locus which
are not amorphic and hence not detectable
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FIGURE 6. Dosimetry of EMS in the TK'-->
TK-'- mutation assay system: (*) extent of
alkylation of the DNA was determined following a
2 hr exposure to ['H]-EMS (constant radioactiv-
ity over indicated EMS range); (M) induced
mutant frequencies were measured as usual follow-
ing the standard 2 hr exposure; (0) the ratio,
number of mutations/alkylation, is essentially con-
stant at 0.8 X 0l over a 5-fold variation of EMS
concentration (1.0-5.0 mM).
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1%o of all TK mutants to be amorphic, we
still have a figure of approximately 1 muta-
tion per 100 alkylations, raising the possi-
bility of a 99%o level of repair efficiency.
It would appear from the foregoing that
the TK+/- .JTK-/- L5178Y mouse lymphoma
mutagen assay system is (1) faster than a
breeding mammal; (2) able to eke much
data from a simple experiment; (3) more
relevant than Salmonella; and (4) able to
distinguish quantitatively among the muta-
genicities of closely related analogs (e.g.,
EMS, MMS; hycanthone, IA-3). Addition-
ally, an attempt has been made to present
these data in a form which encourages com-
parison with other systems (since toxicity
is an easily quantitated parameter) and of
extrapolation to man. Weaknesses do exist
and these have been briefly touched upon.
But some of these weaknesses might be sur-
mountable. Certainly the absence of host
metabolism can be at least partially over-
come by coupling the test system as de-
scribed to a microsomal activation system
such as that described by Malling and Frantz
(9) or by utilizing these cells as indicator
organisms in a host-mediated assay, as dis-
cussed by Capizzi (10) and Lee (11).
Conclusions
The mammalian cell culture system just
described helps bridge the gulf between
microbial-especially prokaryotic-systems
and whole mammal systems presently in use
for mutagenicity studies. Such a claim fol-
lows from the fact that these lymphoma cells
retain both a typically mammalian archi-
tecture (down to and including the genome)
and certain facets of mammalian metabol-
ism. Quantitative aspects of mutagenesis
have been emphasized and mutagens can be
classified as strong, weak, or of intermediate
potency on the basis of their mutagenicity:
growth inhibition curves. In an attempt to
improve upon growth inhibition as a dosi-
metric measure, we have determined the re-
lationship between extent of EMS-induced
alkylation and resultant mutant frequency,
and plan on extending such studies to other
mutagens. Finally, a number of hycanthone
analogs are being studied; one of these has
been shown to exert possibly negligible
mutagenicity at concentrations which are
highly inhibitory to growth. It is hoped that
such studies can lead to a safe hycanthone
substitute for the control of schistosomiasis.
This workshop has demonstrated that basic
agreement presently exists on the desirability
of multiple test systems; multiple test sys-
tems exist, each with their characteristic
strengths and weaknesses, for screening and
safety testing programs; a possible hier-
archv of such programs has been described
by Bridges (12). We can move on to the
real world where mutagens do not attack in
single file but en masse; where the target
cells are not intraperitoneal, but gonadal;
where the issue is not only dead fetuses, but
an imperceptibly debilitating population; and
where Salmonella sapiens does not exist.
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